These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31230818)

  • 1. Prognostic value of cyclin A2 and B1 expression in lung carcinoids.
    Brcic L; Heidinger M; Sever AZ; Zacharias M; Jakopovic M; Fediuk M; Maier A; Quehenberger F; Seiwerth S; Popper H
    Pathology; 2019 Aug; 51(5):481-486. PubMed ID: 31230818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
    Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
    Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids.
    Swarts DR; Rudelius M; Claessen SM; Cleutjens JP; Seidl S; Volante M; Ramaekers FC; Speel EJ
    Histopathology; 2017 Feb; 70(3):412-422. PubMed ID: 27701763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive pathological and clinical features of lung carcinoids with high proliferation index.
    Marchiò C; Gatti G; Massa F; Bertero L; Filosso P; Pelosi G; Cassoni P; Volante M; Papotti M
    Virchows Arch; 2017 Dec; 471(6):713-720. PubMed ID: 28631159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors: Ki-67 Index Predicts Progression-free Survival and Atypical Histology.
    Naso JR; Jenkins SM; Roden AC; Yi ES; Lo YC; Bois MC; Maleszewski JJ; Aubry MC; Boland JM
    Am J Surg Pathol; 2024 Jun; 48(6):742-750. PubMed ID: 38584496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.
    Clay V; Papaxoinis G; Sanderson B; Valle JW; Howell M; Lamarca A; Krysiak P; Bishop P; Nonaka D; Mansoor W
    Clin Transl Oncol; 2017 May; 19(5):579-586. PubMed ID: 27848218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
    Rekhtman N; Desmeules P; Litvak AM; Pietanza MC; Santos-Zabala ML; Ni A; Montecalvo J; Chang JC; Beras A; Preeshagul IR; Sabari JK; Rudin CM; Ladanyi M; Klimstra DS; Travis WD; Lai WC
    Mod Pathol; 2019 Jul; 32(8):1106-1122. PubMed ID: 30923345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung.
    Garg R; Bal A; DAS A; Singh N; Singh H
    Turk Patoloji Derg; 2019; 35(1):15-21. PubMed ID: 30070306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors.
    Walts AE; Ines D; Marchevsky AM
    Mod Pathol; 2012 Sep; 25(9):1258-64. PubMed ID: 22575865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of Ki-67 labeling index to grade pulmonary well-differentiated neuroendocrine neoplasms: current best evidence.
    Marchevsky AM; Hendifar A; Walts AE
    Mod Pathol; 2018 Oct; 31(10):1523-1531. PubMed ID: 29802361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascl1 and OTP tumour expressions are associated with disease-free survival in lung atypical carcinoids.
    Centonze G; Maisonneuve P; Simbolo M; Lagano V; Grillo F; Prinzi N; Pusceddu S; Missiato L; Colantuono M; Sabella G; Bercich L; Mangogna A; Rolli L; Grisanti S; Benvenuti MR; Pastorino U; Roz L; Scarpa A; Berruti A; Capella C; Milione M
    Histopathology; 2023 May; 82(6):870-884. PubMed ID: 36720841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
    Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
    Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor.
    Vesterinen T; Mononen S; Salmenkivi K; Mustonen H; Räsänen J; Salo JA; Ilonen I; Knuuttila A; Haglund C; Arola J
    Acta Oncol; 2018 Aug; 57(8):1109-1116. PubMed ID: 29463166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI-67-labeling study.
    Costes V; Marty-Ané C; Picot MC; Serre I; Pujol JL; Mary H; Baldet P
    Hum Pathol; 1995 Jul; 26(7):740-5. PubMed ID: 7628845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver variability for the WHO classification of pulmonary carcinoids.
    Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ
    Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor characteristics, expressions of ERCC1, Bax, p53, IGF1R, Bcl2, Bcl2/Bax and prognostic factors for overall survival in patients with lung carcinoid.
    Velinovic M; Jankovic R; Jovanovic D; Skodric Trifunovic V; Gavrilovic D; Stojsic J; Cavic M
    J BUON; 2019; 24(1):256-266. PubMed ID: 30941978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical bronchopulmonary carcinoids show a tendency toward increased apoptotic and proliferative activity.
    Laitinen KL; Soini Y; Mattila J; Pääkkö P
    Cancer; 2000 Apr; 88(7):1590-8. PubMed ID: 10738217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Cyclins A2, B1, D1, and E1 and
    Monteiro LS; Diniz-Freitas M; Warnakulasuriya S; Garcia-Caballero T; Forteza-Vila J; Fraga M
    Anal Cell Pathol (Amst); 2018; 2018():7253510. PubMed ID: 29785357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.
    Skov BG; Holm B; Erreboe A; Skov T; Mellemgaard A
    J Thorac Oncol; 2010 Apr; 5(4):453-9. PubMed ID: 20104194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposal of a Panel of Genes Identified by miRNA Profiling as Candidate Prognostic Biomarkers in Lung Carcinoids.
    Rapa I; Votta A; Giorcelli J; Izzo S; Rigutto A; Metovic J; Napoli F; Volante M
    Neuroendocrinology; 2021; 111(1-2):115-122. PubMed ID: 32040954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.